Intel Corporation v. Proxense, LLC

This Inter Partes Review (IPR) case, Intel Corporation v. Proxense, LLC (IPR2025-00327), concerned U.S. Patent No. 9,265,043. The petitioner, Intel Corporation, is an American multinational technology company and a leading manufacturer of semiconductor computer circuits, including CPUs, chipsets, and wireless components. The patent owner, Proxense, LLC, is identified as a non-practicing entity (NPE) and a former operating company that focuses on enforcing patents related to biometric authentication and wireless communication technology.

The IPR was initiated in response to an underlying patent infringement lawsuit filed by Proxense against Intel in the U.S. District Court for the Western District of Texas (case number 6:24-cv-00283). In that district court litigation, Proxense accused Intel of infringing its patents, including the '043 patent, through the provision of adapters, gateways, and integrated processors that support Wi-Fi 6 and later technologies, as well as those offering Trusted Platform Module (TPM) functionality required by Windows 11 operating systems. U.S. Patent No. 9,265,043, titled "Dynamic Real-Time Tiered Client Access," generally describes systems and methods for wireless data exchange between a client device and a proximity-based reader device for authentication and access control based on dynamically assigned access tiers.

Filed on December 23, 2024, at the Patent Trial and Appeal Board (PTAB), the IPR was instituted and subsequently terminated on June 26, 2025. The termination was a discretionary denial issued by Acting Director Coke Morgan Stewart. This decision is notable because it reaffirmed the PTAB's "settled expectations" doctrine, which disfavors institution of IPRs for patents that have been in force for many years (in this case, over nine years) unless the petitioner can provide persuasive reasons, such as a significant change in law or evidence that the patent had not been commercialized or asserted in the relevant technology space. While this IPR was denied institution, Intel later settled its broader patent dispute with Proxense in March 2026, consistent with Proxense's history of multi-patent enforcement campaigns against major tech companies like Google, Apple, and Microsoft.

This case involves an Inter Partes Review (IPR) initiated by Intel Corporation against Proxense, LLC (IPR2025-00327) concerning U.S. Patent No. 9,265,043. This IPR was filed in response to a patent infringement lawsuit brought by Proxense against Intel in the U.S. District Court for the Western District of Texas (Case No. 6:24-cv-00283).

Here is a chronological summary of the key legal developments and outcomes:

District Court Patent Infringement Litigation (Proxense LLC v. Intel Corp., W.D. Texas, Case No. 6:24-cv-00283):

• Filing & Initial Pleadings:

  • 2024-05-23: Proxense, LLC filed a patent infringement complaint against Intel Corporation in the Western District of Texas. The lawsuit asserted infringement of U.S. Patent No. 9,265,043, among others, including U.S. Patent Nos. 8,036,152, 8,219,129, 8,352,730, and 8,457,672.
  • 2024-09-02: Proxense filed an amended complaint.

• Claim Construction (Markman):

  • 2025-03-28: A Markman (claim construction) hearing was held in the district court.
  • 2025-05-08: The court issued its final claim constructions for the patents at issue, including U.S. Patent No. 9,265,043.

• Final Disposition:

  • 2025-10-17: A consent judgment of non-infringement was entered in the district court case.
  • 2026-03-23: The district court case was terminated, following a settlement between Proxense and Intel.

Parallel PTAB IPR Proceedings (Intel Corporation v. Proxense, LLC, IPR2025-00327):

• Filing:

  • 2024-12-23: Intel Corporation filed an Inter Partes Review petition (IPR2025-00327) challenging the patentability of U.S. Patent No. 9,265,043 at the Patent Trial and Appeal Board (PTAB). This filing was recorded as an event in the related district court litigation.

• Termination & Outcome:

  • 2025-06-26: The PTAB issued a Director Discretionary Decision to deny institution of IPR2025-00327. The IPR was therefore terminated on this date.
  • The denial was based on the "settled expectations" doctrine, a discretionary ground for denying IPR petitions, particularly for older patents. Acting Director Coke Morgan Stewart reasoned that U.S. Patent No. 9,265,043 had been in force for over nine years, creating settled expectations, and Intel did not provide persuasive reasons to justify using PTAB resources for review. This decision, along with others from the same period, provided guidance on how the "settled expectations" factor would be applied, noting that a significant change in law or evidence that the patent had not been commercialized, asserted, or licensed could potentially overcome this doctrine.

Effect of IPR on Litigation:

The PTAB's discretionary denial of institution meant that the IPR did not proceed to a full trial on the merits of patentability. Therefore, the IPR had no direct impact on the validity findings in the district court. The district court litigation proceeded through claim construction and ultimately concluded with a consent judgment of non-infringement and a settlement between the parties.

I'll start by verifying the listed articles and searching for coverage of this specific IPR.

Law firm coverage exists. Now let me check the listed IPWatchdog articles and search for broader press coverage of the Intel–Proxense dispute.

Press and commentary coverage

The short version: I found no mainstream business or trade-news coverage (Reuters, Bloomberg Law, Law360, Ars Technica) of IPR2025-00327. What exists is a well-developed cluster of law-firm PTAB commentary treating the June 26, 2025 decision as a precedent-setting ruling on the "settled expectations" doctrine, plus litigation-database write-ups on the underlying West Texas case. Coverage is about the rule, not the fight.

What the commentary says happened. Finnegan (also republished on Lexology, July 7, 2025) reported that Acting Director Coke Morgan Stewart issued discretionary denials in a trio of related petitions — IPR2025-00327, -00328 and -00329, Paper 12 (PTAB June 26, 2025) — reasoning that "the challenged patents have been in force over nine years, creating settled expectations, and Petitioner does not provide any persuasive reasoning why an inter partes review is an appropriate use of Board resources." Bookoff McAndrews (Aug. 11, 2025) placed the ruling in the chain running from the Acting Director's March 26, 2025 "Interim Process for PTAB Workload Management" memorandum, and The Patent Playbook via Lexology (July 18, 2025) noted the decision landed one week after the iRhythm denials. The decision itself, reproduced here, confirms the outcome: "ORDERED that Patent Owner's request for discretionary denial is granted; and FURTHER ORDERED that the Petition is denied," under 35 U.S.C. § 314(a).

Why outlets consider it significant. Every account frames Intel v. Proxense as the first decision giving petitioners a roadmap out of settled expectations. National Law Review (Bradford C. Frese and Saukshmya Trichi, ArentFox Schiff; Vol. XV, No. 205) reported two carve-outs: a "significant change in law" occurring since issuance that "directly bears on the patentability of the challenged claims," and evidence the patent was not "commercialized, asserted, marked, licensed, or otherwise applied in a petitioner's particular technology space, if at all." Sterne Kessler (originally in Managing IP, Oct. 15, 2026) goes furthest beyond the record, reporting that "commentators have since identified an effective six-year settled-expectations threshold," that institution rates fell and PTAB petitions dropped more than 60% year-over-year, and that the doctrine's fate turns on a pending certiorari petition in Google v. VirtaMove, No. 25-1230. The decision has real downstream citation value: a patent owner in unrelated PTAB cases asked the Director for authorization to file replies citing Proxense and its licensing-evidence reasoning (PTAB filing), and a Board decision quoting the Proxense "persuasive reasons" language appears in the appeal papers in SanDisk (Fed. Cir. No. 25-152) (reproduced PDF).

What reporting does not cover. No source I found reports any damages figure, settlement term, or market impact for this IPR — unsurprising since the petition was never instituted and the merits were never reached. The district-court side, Proxense, LLC v. Intel Corp., No. 6:24-cv-00283 (W.D. Tex., Judge Alan Albright), is covered almost entirely by litigation-data vendors rather than journalists: Patsnap reports the case was filed May 23, 2024 and closed March

Sources

• FINNEGAN
• Intel from Intel: Acting Director Gives Guidance on How to Defeat Settled Expectations - Register now for your free, tailored, daily legal newsfeed service.
• From: Director_Discretionary_Decision To: Colette Woo; Director_Discretionary_Decision To: Nathan Lowenstein; Kenneth Weatherwax...
• In Intel Corp
• Intel From Intel: Acting Director Gives Guidance On How To Defeat Settled Expectations - ARTICLE
• Overcoming the ‘Settled Expectations’ Doctrine: Guidance From Intel v. Proxense - Published on The National Law Review https://dev
• Case IPR2025- 00517 U
• UNITED STATES PATENT AND TRADEMARK OFFICE
• Docket Alarm | Litigation Outcomes, Delivered - - All Courts
• At the PTAB Blog Blog - Articles: 41-50 of 313
• strong settled expectations for Patent Owner
• UNITED STATES PATENT AND TRADEMARK OFFICE

Intel Corporation, the plaintiff in IPR2025-00327, was represented by attorneys from Goodwin Procter LLP. The case was ultimately denied institution by the PTAB based on the "settled expectations" doctrine.

Counsel of record for Intel Corporation include:

• Lori A. Gordon
  • Role: Likely lead counsel or a key attorney given her listing.
  • Firm: Goodwin Procter LLP
  • Office Location: While not specified in the search results for this case, Goodwin Procter has offices in various major cities, including Boston, New York, Washington D.C., and several in California. A general search for Lori A. Gordon at Goodwin Procter would be needed to pinpoint her specific office.
  • Experience: Further research would be needed to detail her specific patent litigation experience.
• Christie Larochelle
  • Role: Attorney
  • Firm: Goodwin Procter LLP
  • Office Location: Not specified in the search results.
  • Experience: Further research would be needed to detail her specific patent litigation experience.

The provided search results indicate that there were potentially seven more attorneys representing Intel, but their names were not explicitly listed.

Intel also engages various firms for its broader patent litigation efforts, including Williams & Connolly LLP and Desmarais LLP for district court cases, and has in-house counsel such as Steven R. Rodgers, Senior Vice President and General Counsel. However, for this specific IPR, the identified firm is Goodwin Procter LLP.

Proxense, LLC was represented by the following counsel:

• Name: David L. Hecht
  • Role: Lead Counsel
  • Firm: Hecht Partners LLP
  • Office Location: While not explicitly stated for this IPR, Hecht Partners LLP has offices in New York and other locations.
  • Relevant Experience: David L. Hecht has a notable history of representing Proxense, LLC in numerous patent disputes, including other Inter Partes Reviews (IPRs) and related appeals at the Federal Circuit. He was previously at Quinn Emanuel during the "Smartphone Patent Wars" and has experience with copyright-related work. He has been counsel for Proxense in other PTAB petitions brought by Intel, which were denied. He also represents Proxense in patent infringement complaints against major technology companies in district courts.